BioMarin appoints chairman and CEO

BioMarin (BMRN; SWX:BMRN), which develops therapeutic carbohydrate-active enzymes, hired Fredric Price as chairman and CEO, replacing Grant Denison, who will continue on the board. Price was formerly ...